{
    "id": 20469,
    "cites": 32,
    "cited_by": 3,
    "reference": [
        "Akunyili, Dora (2005) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Counterfeit and Substandard Drugs, Nigeria\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s Experience: Implications, Challenges, Actions and Recommendations,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 speech at the World Bank, accessed at www.siteresources.worldbank.org on August 1, 2014.",
        "Arora, Ashish, Lee Branstetter and Chirantan Chatterjee (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Strong Medicine: Patent Reform and the Emergence of a Research-Driven Pharmaceutical Industry in India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 working paper, accessed at www.reseaerchgate.net on August 26, 2014.",
        "Attaran, Amir, Donna Barry, Shamnad Basheer, Roger Bate, David Benton, James Chauvin, Laurie Garrett, Ilona Kickbusch, Jillian Clare Kohler, Kamal Midha, Paul N Newton, Sania Nishtar, Paul Orhii, and Martin McKee (November 2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2How to achieve international action on falsified and substandard medicines.\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 British Medical Journal 2012: 345.",
        "Bate, Roger (2012) Phake: The Deadly World of Falsified and Substandard Medicines. American Enterprise Institute Press.",
        "Bate, Roger, Ginger Zhe Jin, and Aparna Mathur (2011) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Does Price Reveal Poor-Quality Drugs? Evidence from 17 Countries,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Journal of Health Economics 30 (6): 1150\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c1163.",
        "Bate, Roger, Lorraine Mooney, Emily Putze, Alexandra McPherson, and Sarah Naoshy (2010) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Drug Registration: A Necessary but Not Sufficient Condition for Good Quality Drugs: A Preliminary Analysis of Twelve Countries,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Africa Fighting Malaria Working Paper.",
        "Bate, Roger, Kimberly Hess and Lorraine Mooney (2010) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Medicine Registration and Medicine Quality: A Preliminary Analysis of Key Cities in Emerging Markets,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Research and Reports in Tropical Medicine, December 2010, vol 1. Pp 89-93, doi 10.2147/RRTM. S15199.",
        "Bate, Roger, Ginger Zhe Jin and Aparna Mathur (2014) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Falsified or Substandard? Assessing Price and Non-Price Signals of Drug Quality\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 forthcoming Journal of Economics & Management Strategy. Also available as NBER Working Paper #18073.",
        "Binagwaho, Agnes, Roger Bate, Micahel Gasana, Corine Karema, Yves Mucyo, John Patrick Mwesigye, Floribert Biziyaremye, Cameron Nutt, Clare Wagner, Paul Jensen, and Amir Attaran (2013) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Substandard and Falsified Medicines: A View from Rwanda\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 PLOS Medicine July 02, 2013, doi: 10.1371/journal.pmed.1001476.",
        "Cameron, Alexandra, Margaret Ewen, Dennis Ross-Degnan, D. Ball, and Richard Laing (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 The Lancet December 1, 2008.",
        "Chaudhuri, Shubham, PinelopiGoldberg and Panle Jia (2006) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 American Economic Review, 96(5): 1477-1513.",
        "Cockburn, Iain, Jean Lanjouw and Mark Schankerman (2014) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Global Diffusion of New Drugs: Patent Policy, Price Controls and Institutions,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 abstract accessed at http:/www.tigerforum.",
        "Duggan, Mark and Aparajita Goyal (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Pharmaceutical Patents and Prices: A Preliminary Empirical Assessment Using Data from India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 World Bank Policy Research Working Paper #6063.",
        "International Monetary Fund (IMF) (2009-2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2World Economic Outlook Database.\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Institute of Medicine (IOM) (2013), Countering the Problem of Falsified and Substandard Drugs, National Academy of Sciences, ISBN 978-0-309-26939-1.",
        "J\u00c3\u0083\u00c2\u00a4hnke, R. W. O., G. K\u00c3\u0083\u00c2\u00bcsters, and K. Fleischer (2001) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Low-cost quality assurance of medicines using the GPHF-Minilab,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Drug Information Journal 35:941-945.",
        "Kaale, Eliangiringa, Peter Risha, and Thomas Layloff (2011) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2TLC for pharmaceutical analysis in resource limited countries.\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Journal of Chromatography A 1218(19):2732-2736.",
        "Kelesidis, Theodore, Iosif Kelesidis, Petros I. Rafailidis and Matthew E. Falagas (2007) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Counterfeit or Substandard Antimicrobial Drugs: A Review of the Scientific Evidence\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Journal of Antimicrobial Chemotherapy 60: 214-236.",
        "KPMG (2006) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2The Indian Pharmaceutical Industry: Collaboration for Growth\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 accessed at https://www.in.kpmg.com/pdf/Indian%20Pharma%20Outlook.pdf on June 16, 2014.",
        "Kyle, Margaret and Anita McGahan (2012) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Investments in Pharmaceuticals Before and After TRIPS.\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Review of Economics and Statistics, 94 (4): 1157-1172.",
        "Kyle, Margaret and Yi Qian (2013) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Intellectual Property Rights and Access to Innovation: Evidence from TRIPS\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 working paper.",
        "McKinsey (2013) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Generating value in generics: Finding the next five years of growth\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 accessed at http://www.mckinsey.com/~/media/McKinsey/dotcom/client_service/Pharma%20and%20Medical%2 0Products/PMP%20NEW/PDFs/Generating_value_in_generics_June%202013.ashx on August 29, Ministry of Chemicals & Fertilizers, Department of Pharmaceuticals (MCFDP), Government of India, Annual Report, 2011-2012, accessed at http://pharmaceuticals.gov.in/annualreport2012.pdf on June 16, 2014.",
        "Property Rights Alliance (PRA) (2007-2013) International Property Rights Index.",
        "PWC (2009) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Which are the largest city economies in the world and how might this change by 2025?\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 PricewaterhouseCoopers UK economic Outlook November 2009.",
        "Raufu, Abiodun (2003) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2India agrees to help Nigeria tackle the import of fake drugs,\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 British Medical Journal 326:1234.",
        "Seiter, Andreas (2010) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2A Practical Approach to Pharmaceutical Policy\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093, World Bank Press.",
        "Sharma, Prabodh, Sanjeev Kumar, Rakesh Pahwa and Archana Sharma (2008) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Opportunities for Generic Drugs in India\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Internet Scientific Publications, 8 (1) 2008.",
        "Torstensson, David and Meir Pugatch (2010) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Keeping Medicines Safe \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c A Study of the Regulations Guiding the Approval of Medicines in Emerging Markets\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 Stockholm Network, accessed at http://www.stockholm-network.org/Publications/5 on June 1, 2014.",
        "United Nations (2010) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2World Urbanization Prospects, the 2009 Revision\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 March 2010.",
        "United Nations Development Programme (UNDP) (2009) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Human Development Report 2009.",
        "Overcoming Barriers: Human mobility and development\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 2009.",
        "United States Pharmacopeial Convention (USP) (2013) \u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u00a2Post-Market Quality Surveillance Project: Maternal Healthcare Products (Oxytocin and Ergometrine) on the Ghanaian Market\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u0093 accessed at http://www.usp.org/sites/default/files/usp_pdf/EN/PQM/ghana-mch_mqm_report_finalmar_27_2013_rdct.",
        "pdf on August 29, 2014 World Justice Project (2010, 2012, 2014) Rule of Law Index."
    ]
}